We are live on
!
Find out more
Artisan Partners Portfolio holdings
AUM
$63.1B
Turnover
26.74%
1-Year Est. Return
35.51%
This Fund
S&P 500
This Quarter
Est. Return
+13.03%
1 Year Est. Return
+35.51%
3 Year Est. Return
+129.08%
5 Year Est. Return
+159.14%
10 Year Est. Return
+803.1%
AUM
$68.3B
AUM Growth
+$6.4B
(+10%)
Cap. Flow
-$428M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
22.43%
Holding
388
New
45
Increased
116
Reduced
171
Closed
46
Avg Time Held Equity + Options
3
years
Top 10 Avg Time Held Equity + Options
1.3
years
Top 20 Avg Time Held Equity + Options
2.9
years
Avg Time Held Equity only
3.1
years
Top 10 Avg Time Held Equity only
1.3
years
Top 20 Avg Time Held Equity only
2.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IQVIA
IQV
|
+$493M |
| 2 |
Icon
ICLR
|
+$410M |
| 3 |
Cencora
COR
|
+$396M |
| 4 |
Suncor Energy
SU
|
+$339M |
| 5 |
Atlassian
TEAM
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$420M |
| 2 |
Marvell Technology
MRVL
|
+$338M |
| 3 |
Apple
AAPL
|
+$291M |
| 4 |
argenx
ARGX
|
+$253M |
| 5 |
Netflix
NFLX
|
+$208M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.43% |
| 2 | Technology | 21.87% |
| 3 | Healthcare | 17.9% |
| 4 | Communication Services | 10.23% |
| 5 | Industrials | 8.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
301
SolarEdge
SEDG
$1.94B
| $15.1M | 0.02% |
739,701
-38,776
| -5% | -$641K |
2025 Q1
1 quarter
|
|
302
Wave Life Sciences
WVE
$615M
| $14.7M | 0.02% |
2,264,835
-105,318
| -4% | -$695K |
2024 Q3
3 quarters
|
|
303
VanEck Vietnam ETF
VNM
$460M
| $14.2M | 0.02% |
1,033,985
-848,632
| -45% | -$10.8M |
2024 Q2
4 quarters
|
|
304
Ionis Pharmaceuticals
IONS
$7.15B
| $14M | 0.02% |
354,962
+151,784
| +75% | +$4.97M |
2024 Q1
5 quarters
|
|
305
CAVA Group
CAVA
$6.62B
| $13.9M | 0.02% |
+165,462
| New | +$14.1M |
2025 Q2
0 quarters
|
|
306
BridgeBio Pharma
BBIO
$13B
| $13.7M | 0.02% |
318,287
-20,118
| -6% | -$732K |
2025 Q1
1 quarter
|
|
307
Globant
GLOB
$1.7B
| $13.2M | 0.02% |
145,707
+37,432
| +35% | +$4M |
2021 Q4
14 quarters
|
|
308
Axalta
AXTA
$7.15B
| $13M | 0.02% |
439,474
+49,510
| +13% | +$1.54M |
2021 Q3
15 quarters
|
|
309
Agios Pharmaceuticals
AGIO
$1.88B
| $13M | 0.02% |
389,984
-20,688
| -5% | -$627K |
2024 Q2
4 quarters
|
|
310
Rhythm Pharmaceuticals
RYTM
$5.98B
| $11M | 0.02% |
+174,479
| New | +$10.7M |
2025 Q2
0 quarters
|
|
311
Equinix
EQIX
$96.9B
| $10.6M | 0.02% |
13,386
-69,366
| -84% | -$58.8M |
2024 Q3
3 quarters
|
|
312
Intercontinental Exchange
ICE
$89.9B
| $10.6M | 0.02% |
57,520
+15,255
| +36% | +$2.62M |
2024 Q4
2 quarters
|
|
313
VTEX
VTEX
$693M
| $10.5M | 0.02% |
1,596,050
+126,875
| +9% | +$745K |
2023 Q4
6 quarters
|
|
314
Ocular Therapeutix
OCUL
$1.53B
| $9.89M | 0.01% |
1,065,969
-89,107
| -8% | -$697K |
2024 Q3
3 quarters
|
|
315
Cable One
CABO
$43.2M
| $9.77M | 0.01% |
71,960
-88,755
| -55% | -$16.7M |
2022 Q2
12 quarters
|
|
|
VRNA
316
DELISTED
Verona Pharma
VRNA
| $8.14M | 0.01% |
86,101
+4,622
| +6% | +$342K |
2025 Q1
1 quarter
|
|
317
Everest Group
EG
$14.8B
| $7.6M | 0.01% |
22,375
+1,289
| +6% | +$445K |
2024 Q4
2 quarters
|
|
318
Aris Mining
ARIS
$3.58B
| $7.44M | 0.01% |
1,107,807
-189,272
| -15% | -$1.12M |
2024 Q1
5 quarters
|
|
319
Nurix Therapeutics
NRIX
$2.69B
| $6.61M | 0.01% |
580,749
-57,860
| -9% | -$625K |
2025 Q1
1 quarter
|
|
320
Celcuity
CELC
$2.74B
| $5.36M | 0.01% |
401,678
-52,968
| -12% | -$577K |
2024 Q2
4 quarters
|
|
321
iShares MSCI India ETF
INDA
$5.91B
| $5.19M | 0.01% |
+93,240
| New | +$4.98M |
2025 Q2
0 quarters
|
|
322
Replimune Group
REPL
$1.03B
| $4.75M | 0.01% |
511,371
-53,704
| -10% | -$469K |
2024 Q4
2 quarters
|
|
323
Natera
NTRA
$56.6B
| $4.29M | 0.01% |
+25,369
| New | +$3.95M |
2025 Q2
0 quarters
|
|
324
Stryker
SYK
$113B
| $4.17M | 0.01% |
10,530
-1,134
| -10% | -$424K |
2021 Q4
14 quarters
|
|
325
Vir Biotechnology
VIR
$1.7B
| $3.99M | 0.01% |
791,611
| – | – |
2024 Q4
2 quarters
|
|
Similar funds
Artisan Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Artisan Partners held 388 positions worth $68.3B, up 10% from $61.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Artisan Partners's Q2 2025 filing shows 45 new, 116 increased, 171 reduced and 46 closed positions. Its largest new stake was IQVIA: 3,272,872 shares worth $516M. The largest sale was Alibaba, an estimated $420M.
By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- Artisan Partners's largest Q2 2025 buy was IQVIA: 3,272,872 shares worth $516M.
- Artisan Partners added most to Icon in Q2 2025, an estimated $410M increase.
- Artisan Partners's biggest Q2 2025 reduction was Apple, cutting an estimated $291M.
- Artisan Partners fully exited Alibaba in Q2 2025, selling an estimated $420M.
- Artisan Partners's ten largest holdings make up 22% of its $68.3B portfolio in Q2 2025.
- Artisan Partners opened 45 new positions and closed 46 in Q2 2025.
- Artisan Partners's portfolio value rose 10% quarter-over-quarter to $68.3B.
Based on Artisan Partners's 13F filing for Q2 2025, filed 12 Aug 2025.